Joel Greenblatt - Gotham Asset Management
Holding/activity history for Nektar Therapeutics (NKTR)
← All NKTR superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2019 Q1 | 0 | 0.00 | Sell 100.00% | 0.09 | $470.40–706.65 · VW $587.70i | SEC | |
| 2018 Q4 | 12,073 | 0.09 | Reduce 42.51% | 0.11 | $438.30–903.75 · VW $595.54i | $5,953,000 | SEC |
| 2018 Q3 | 20,999 | 0.27 | Add 7563.87% | 0.26 | $685.35–1,046.40 · VW $872.55i | $19,202,000 | SEC |
| 2018 Q2 | 274 | <0.01 | Reduce 7.74% | <0.01 | $667.65–1,623.45 · VW $1,058.71i | $201,000 | SEC |
| 2018 Q1 | 297 | <0.01 | Reduce 4.19% | <0.01 | $819.45–1,670.40 · VW $1,330.67i | $473,000 | SEC |
| 2017 Q4 | 310 | <0.01 | Buy | <0.01 | $340.80–928.20 · VW $661.77i | $278,000 | SEC |
| 2015 Q3 | 0 | 0.00 | Sell 100.00% | 0.15 | $137.40–216.60 · VW $176.24i | SEC | |
| 2015 Q2 | 90,928 | 0.15 | Buy | 0.15 | $142.65–208.95 · VW $172.54i | $17,063,000 | SEC |